Tag
Drug Discovery
Jan 12, 2023
Drug Discovery scientist wants to speed up development of new cancer therapeutics
Drug Discovery scientist wants to speed up development of new cancer therapeutics
Sep 27, 2022
The Next Generation: Mahmoud Noureldin
The Next Generation: Mahmoud Noureldin
Aug 29, 2022
Previously overlooked proteins are a potential source for a new class of cancer killing drugs
Previously overlooked proteins are a potential source for a new class of cancer killing drugs
Nov 25, 2020
Cancer research through COVID: A drug discovery student's perspective
Cancer research through COVID: A drug discovery student's perspective
Jul 21, 2020
OICR Drug Discovery awarded for COVID-19 research
OICR Drug Discovery awarded for COVID-19 research
Jun 17, 2020
Inside OICR’s Drug Discovery Lab: A graduate student’s unique collaborative experience
Inside OICR’s Drug Discovery Lab: A graduate student’s unique collaborative experience
Jun 16, 2020
OICR joins European consortium to ‘enable and unlock biology in the open’
OICR joins European consortium to ‘enable and unlock biology in the open’
Jun 11, 2020
Community-driven initiative finds new potential avenue of ovarian cancer treatment
Community-driven initiative finds new potential avenue of ovarian cancer treatment
May 20, 2020
Study points to common protein duo as a new therapeutic target for several cancer types
Study points to common protein duo as a new therapeutic target for several cancer types
Feb 27, 2020
Innovative drug screening method finds new promising molecules to treat aggressive lung cancers
Innovative drug screening method finds new promising molecules to treat aggressive lung cancers
Nov 01, 2019
Dr. Rima Al-awar promoted to Head of Therapeutic Innovation and Drug Discovery at OICR
Dr. Rima Al-awar promoted to Head of Therapeutic Innovation and Drug Discovery at OICR
Jul 24, 2019
OICR funding for Ontario drug discovery projects will accelerate development of new cancer therapies
OICR funding for Ontario drug discovery projects will accelerate development of new cancer therapies
May 21, 2019
Activating the immune system to fight cancer
Activating the immune system to fight cancer
Mar 08, 2019
Moving in vivo: A case of navigating through translational research roadblocks
Moving in vivo: A case of navigating through translational research roadblocks
Feb 21, 2019
OICR supports cancer drug discovery in Ontario with new funding for four promising early-stage projects
OICR supports cancer drug discovery in Ontario with new funding for four promising early-stage projects
Jan 29, 2019
First-in-class drug for blood cancers discovered by Ontario researchers receives record-setting industry investment
First-in-class drug for blood cancers discovered by Ontario researchers receives record-setting industry investment
Sep 13, 2018
FACIT invests in three top Ontario entrepreneur-teams from near record pool of applicants
FACIT invests in three top Ontario entrepreneur-teams from near record pool of applicants
Sep 04, 2018
Meet our students - 2018
Meet our students - 2018
Aug 22, 2018
Meet the researchers: Ratheesh Subramaniam
Meet the researchers: Ratheesh Subramaniam
Jul 31, 2018
Can an open drug discovery model find a solution for rare brain cancers in children?
Can an open drug discovery model find a solution for rare brain cancers in children?
Dec 04, 2017
OICR launches groundbreaking Cancer Therapeutics Innovation Pipeline to drive cutting-edge therapies to the clinic
OICR launches groundbreaking Cancer Therapeutics Innovation Pipeline to drive cutting-edge therapies to the clinic
Mar 22, 2017
FACIT Announces Investment in Propellon Therapeutics
FACIT Announces Investment in Propellon Therapeutics
Feb 10, 2017
How chemical probes can boost cancer research
How chemical probes can boost cancer research
Dec 06, 2016
Congratulations to Ahmed Aman on another successful Movember fundraiser
Congratulations to Ahmed Aman on another successful Movember fundraiser
Sep 19, 2016
Open resource: How we’re making our research resources more accessible to the community
Open resource: How we’re making our research resources more accessible to the community
Aug 18, 2016
Registration now open for the Mark Ernsting Drug Discovery Memorial Lecture
Registration now open for the Mark Ernsting Drug Discovery Memorial Lecture
Jul 26, 2016
OICR is making its technology infrastructure, expertise and resources more available to the Ontario cancer community
OICR is making its technology infrastructure, expertise and resources more available to the Ontario cancer community
Jul 18, 2016
Save the date: Mark Ernsting Drug Discovery Memorial Lecture on September 22, 2016
Save the date: Mark Ernsting Drug Discovery Memorial Lecture on September 22, 2016
Jun 21, 2016
Ask an expert: How are new cancer drugs created?
Ask an expert: How are new cancer drugs created?
May 01, 2016
OICR invests in early-stage Ontario oncology drug development
OICR invests in early-stage Ontario oncology drug development
Jan 07, 2016
Ontario Institute for Cancer Research invests $1.2 million to support oncology drug development in Ontario
Ontario Institute for Cancer Research invests $1.2 million to support oncology drug development in Ontario
Dec 29, 2015
OICR partnership with Johnson and Johnson to develop new treatments for haematological cancers
OICR partnership with Johnson and Johnson to develop new treatments for haematological cancers
Dec 08, 2015
FACIT Gains Rights to WDR5 Inhibitors for MLL Leukemia
FACIT Gains Rights to WDR5 Inhibitors for MLL Leukemia
Dec 08, 2015
FACIT Gains Rights to WDR5 Inhibitors for MLL Leukemia
FACIT Gains Rights to WDR5 Inhibitors for MLL Leukemia
Oct 14, 2015
OICR, UHN, Novera Therapeutics Announce Collaboration with Johnson & Johnson Innovation on Drug Discovery and Development for Haematological Cancers
OICR, UHN, Novera Therapeutics Announce Collaboration with Johnson & Johnson Innovation on Drug Discovery and Development for Haematological Cancers
Sep 03, 2015
The Ontario Institute for Cancer Research and the Structural Genomics Consortium develop and give away new drug-like molecule to help crowd-source cancer research
The Ontario Institute for Cancer Research and the Structural Genomics Consortium develop and give away new drug-like molecule to help crowd-source cancer research